Dr. Bradley Robottom, MD

NPI: 1558486688
Total Payments
$15,229
2024 Payments
$127.98
Companies
40
Transactions
146
Medicare Patients
3,049
Medicare Billing
$988,276

Payment Breakdown by Category

Research$12,514 (82.2%)
Food & Beverage$2,203 (14.5%)
Consulting$500.00 (3.3%)
Other$11.20 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $12,514 15 82.2%
Food and Beverage $2,203 129 14.5%
Consulting Fee $500.00 1 3.3%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $11.20 1 0.1%

Payments by Type

Research
$12,514
15 transactions
General
$2,714
131 transactions

Top Paying Companies

Company Total Records Latest Year
Eli Lilly and Company $11,156 3 $0 (2019)
Biogen, Inc. $1,359 12 $0 (2017)
US WorldMeds, LLC $797.70 3 $0 (2018)
ABBVIE INC. $406.42 26 $0 (2024)
Allergan, Inc. $222.37 16 $0 (2022)
GENZYME CORPORATION $182.84 8 $0 (2022)
Novartis Pharmaceuticals Corporation $165.73 8 $0 (2024)
Supernus Pharmaceuticals, Inc. $113.70 21 $0 (2017)
EMD Serono, Inc. $64.41 5 $0 (2018)
Merz Pharmaceuticals, LLC $55.87 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $127.98 6 ABBVIE INC. ($55.09)
2023 $453.32 26 AbbVie Inc. ($191.81)
2022 $122.89 6 ABBVIE INC. ($52.00)
2021 $28.53 2 AbbVie Inc. ($28.53)
2020 $44.76 3 Allergan, Inc. ($44.76)
2019 $2,705 18 Eli Lilly and Company ($2,431)
2018 $9,238 33 Eli Lilly and Company ($8,725)
2017 $2,508 52 Biogen, Inc. ($1,359)

All Payment Transactions

146 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
11/20/2024 ABBVIE INC. VYALEV (Drug), DUOPA Food and Beverage In-kind items and services $21.76 General
Category: NEUROSCIENCE
11/01/2024 Lilly USA, LLC AMYVID (Drug), KISUNLA Food and Beverage In-kind items and services $13.68 General
Category: Neuroscience
10/17/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $33.33 General
Category: BOTOX THERAPEUTIC
08/01/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $21.15 General
Category: Neurology
07/30/2024 ARGENX US, INC. VYVGART HYTRULO (Drug) Food and Beverage In-kind items and services $22.34 General
Category: Neurology
02/14/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $15.72 General
Category: Neurology
12/11/2023 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $21.96 General
Category: Neurology
11/08/2023 Merz Pharmaceuticals, LLC Xeomin (Biological) Food and Beverage In-kind items and services $55.87 General
Category: Musculoskeletal
10/30/2023 Microtransponder, Inc. Food and Beverage Cash or cash equivalent $21.87 General
10/23/2023 AbbVie Inc. UBRELVY (Drug) Food and Beverage In-kind items and services $22.51 General
Category: NEUROSCIENCE
10/18/2023 Lundbeck LLC VYEPTI (Biological) Food and Beverage Cash or cash equivalent $31.31 General
Category: NEUROLOGY
10/18/2023 Microtransponder, Inc. Food and Beverage Cash or cash equivalent $13.11 General
09/26/2023 AbbVie Inc. BOTOX (Biological) Food and Beverage In-kind items and services $21.82 General
Category: NEUROSCIENCE
09/19/2023 AbbVie Inc. BOTOX (Biological) Food and Beverage In-kind items and services $13.31 General
Category: BOTOX THERAPEUTIC
08/30/2023 Neurelis, Inc. VALTOCO (Drug) Food and Beverage In-kind items and services $15.01 General
Category: EPILEPSY
08/28/2023 ARGENX US, INC. VYVGART HYTRULO (Drug) Food and Beverage In-kind items and services $18.20 General
Category: Neurology
08/08/2023 Eisai Inc. Leqembi (Drug) Food and Beverage Cash or cash equivalent $18.63 General
Category: Neurology
07/28/2023 Lilly USA, LLC AMYVID (Drug) Food and Beverage In-kind items and services $16.34 General
Category: Neuroscience
07/20/2023 AbbVie Inc. DUOPA (Drug) Food and Beverage In-kind items and services $5.35 General
Category: NEUROSCIENCE
07/19/2023 GE HealthCare Food and Beverage Cash or cash equivalent $11.13 General
07/11/2023 AbbVie Inc. BOTOX (Biological) Food and Beverage In-kind items and services $15.44 General
Category: BOTOX THERAPEUTIC
06/07/2023 AbbVie Inc. BOTOX (Biological) Food and Beverage In-kind items and services $18.47 General
Category: BOTOX THERAPEUTIC
05/30/2023 AbbVie Inc. BOTOX (Biological) Food and Beverage In-kind items and services $19.04 General
Category: BOTOX THERAPEUTIC
05/08/2023 AbbVie Inc. UBRELVY (Drug) Food and Beverage In-kind items and services $9.06 General
Category: NEUROSCIENCE
05/01/2023 GE HealthCare Food and Beverage Cash or cash equivalent $13.98 General

Research Studies & Clinical Trials

Study Name Company Amount Records
ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF LY3303560 IN EARLY SYMPTOMATIC ALZHEIMER'S DISEASE Eli Lilly and Company $10,137 2
Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease Biogen, Inc. $1,359 12
ASSESSMENT OF SAFETY, TOLERABILITY AND EFFICACY OF LY3002813 ALONE AND IN COMBINATION WITH LY3202626 IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE Eli Lilly and Company $1,019 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 19 718 26,637 $1.0M $370,634
2022 12 792 14,339 $537,063 $148,181
2021 11 676 12,929 $481,895 $138,863
2020 19 863 23,837 $993,117 $330,599
Total Patients
3,049
Total Services
77,742
Medicare Billing
$988,276
Procedure Codes
61

All Medicare Procedures & Services

61 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg Office 2023 16 3,140 $282,600 $120,064 42.5%
J2323 Injection, natalizumab, 1 mg Office 2023 13 5,700 $199,500 $109,241 54.8%
J0585 Injection, onabotulinumtoxina, 1 unit Office 2023 18 10,880 $141,440 $51,579 36.5%
J0588 Injection, incobotulinumtoxin a, 1 unit Office 2023 12 4,350 $47,850 $17,477 36.5%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 118 143 $42,900 $17,299 40.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 149 149 $56,620 $15,911 28.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 119 136 $29,920 $11,675 39.0%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 37 37 $15,910 $5,669 35.6%
64616 Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box Office 2023 14 47 $24,910 $5,443 21.9%
96413 Administration of chemotherapy into vein, 1 hour or less Office 2023 30 37 $18,870 $3,398 18.0%
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less Office 2023 37 72 $16,416 $3,171 19.3%
70551 Mri scan of brain without contrast Office 2023 33 33 $65,340 $2,952 4.5%
70553 Mri scan of brain before and after contrast Office 2023 15 15 $33,525 $2,210 6.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 29 32 $4,800 $1,991 41.5%
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour Office 2023 18 72 $11,952 $1,012 8.5%
96375 Injection of additional new drug or substance into vein Office 2023 16 41 $4,100 $477.90 11.7%
A9585 Injection, gadobutrol, 0.1 ml Office 2023 17 1,650 $2,475 $402.59 16.3%
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg Office 2023 16 89 $1,335 $383.65 28.7%
96415 Administration of chemotherapy into vein, each additional hour Office 2023 11 14 $2,324 $276.92 11.9%
J0585 Injection, onabotulinumtoxina, 1 unit Office 2022 18 11,300 $146,900 $55,185 37.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 212 212 $80,560 $24,366 30.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 140 172 $51,600 $21,653 42.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 178 201 $44,220 $17,994 40.7%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 76 76 $32,680 $11,864 36.3%
64616 Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box Office 2022 11 35 $18,550 $4,874 26.3%

About Dr. Bradley Robottom, MD

Dr. Bradley Robottom, MD is a Neurology healthcare provider based in Durham, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1558486688.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bradley Robottom, MD has received a total of $15,229 in payments from pharmaceutical and medical device companies, with $127.98 received in 2024. These payments were reported across 146 transactions from 40 companies. The most common payment nature is "" ($12,514).

As a Medicare-enrolled provider, Robottom has provided services to 3,049 Medicare beneficiaries, totaling 77,742 services with total Medicare billing of $988,276. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Location Durham, NC
  • Active Since 03/20/2007
  • Last Updated 08/03/2011
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • NPI Number 1558486688

Products in Payments

  • Xadago (Drug) $783.41
  • BOTOX (Biological) $329.80
  • TROKENDI XR (Drug) $113.70
  • AUBAGIO (Drug) $98.55
  • UBRELVY (Drug) $96.49
  • LEMTRADA (Drug) $84.29
  • KESIMPTA (Drug) $82.93
  • Zinbryta (Biological) $78.99
  • Rebif (Biological) $64.41
  • Xeomin (Biological) $55.87
  • ACTIVA (Device) $49.67
  • Aimovig (Biological) $49.23
  • Radicava (Drug) $45.92
  • AIMOVIG (Biological) $44.54
  • BOTOX (Drug) $44.40
  • VYVGART HYTRULO (Drug) $40.54
  • VYEPTI (Biological) $31.31
  • AMYVID (Drug) $30.02
  • APTIOM (Drug) $26.03
  • COPAXONE (Drug) $25.10

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Durham